Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Moleculin Biotech, Inc.
MBRX
No signals above threshold for this filing.
Other
Warrant Valued Black Scholes
Institutional Investment
Nol Carryforward Expiration Disclosure
Net Loss Reported
Rsu Psu Vesting Schedule Disclosed
Reverse Stock Split Effected
Equity Compensation Accounting Policy
Nasdaq Minimum Bid Price Delisting Notice
Financing Activities Cash Flow Disclosure
Share Repurchase Activity Disclosed
Deferred Tax Asset Valuation Disclosure
Nol Tax Credit Carryforward
Publication Positive
Core
Lead Asset Progress
Clinical Trial Result
Other
Ipo Net Proceeds Disclosure
Core
Combination Therapy Mentioned
Clinical Trial Result
Indication Expansion
Other
Interim Data Positive
No signals above threshold for this filing.
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Ipo Net Proceeds Disclosure
Other
Reverse Stock Split Effected
Other
Nasdaq Minimum Bid Price Delisting Notice
Nyse Listing Disclosure
Other
Warrant Valued Black Scholes
Institutional Investment
Reverse Stock Split Effected
Market Volatility Risk Disclosure
Tax Cuts And Jobs Act Disclosure
Nasdaq Minimum Bid Price Delisting Notice
Fair Value Hierarchy Reconciliation Disclosed
Rsu Psu Vesting Schedule Disclosed
Personnel Cost Decrease Disclosure
Valuation Allowance Deferred Tax Disclosure
Major Tax Law Change Impact
Stock Option Grant Disclosed
Core
Clinical Trial Result
Lead Asset Progress
Indication Expansion
Core
Combination Therapy Mentioned
Clinical Trial Result
Indication Expansion
Other
Interim Data Positive
Core
Combination Therapy Mentioned
Clinical Trial Result
Lead Asset Progress
Indication Expansion
Other
Interim Data Positive